David Adelman is passionate about using medical technology to dramatically improve both patient outcomes and healthcare economics and currently responsible for the development of strategy and programs to bring Edwards’ transformational product innovations to bear on the rapidly evolving needs of US hospital systems. Edwards Lifesciences, headquartered in Irvine, California, is the global leader in heart valve therapy and acute hemodynamic monitoring. Adelman’s previous experience includes general management responsibilities for a $400M portfolio of critical care products comprised of mature, market leading brands and newer, minimally invasive monitoring modalities. Adelman also led the company’s corporate strategy function, held general management responsibility for several business units in Japan and, earlier in his career, held a variety of marketing, finance and business development positions.
More information